Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NAV and Monthly Update - April 2021

27 May 2021 07:00

RNS Number : 9488Z
Honeycomb Investment Trust PLC
27 May 2021
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

27 May 2021

Honeycomb Investment Trust plc

Honeycomb Investment Trust plc (the "Company" or "Honeycomb") announces that the Investment Manager's monthly factsheet for 30 April 2021 is now available on its website at http://www.honeycombplc.com.

Net Asset Value per Share

The Company announces that its unaudited Net Asset Value ("NAV") per share as at 30 April 2021 on a cum-income basis was 1,021.5 pence, based on a NAV of £360.2 million, and on an ex-income basis was 1,017.8 pence, based on a NAV of £358.9 million. The NAVs have been calculated by Apex Fund Services (UK) Ltd.

The Company delivered a NAV return of 0.73% for the month of April, or 8.9% annualised. NAV has increased from £357.6m in March, to £360.2m at the end of April.

 

Investment Assets remained relatively flat in the month at £613m, from £617m in March. Repayments across senior structured facilities were broadly offset by drawdowns across the senior property portfolio. Returns in the month were driven by a strong annualised credit asset return of 9.0%. The portfolio continues to perform well with strong levels of cash collection.

Pipeline & Market Commentary

 

As the UK economy opens up, the Investment Manager has continued to identify attractive lending opportunities, with a near term pipeline of £1.1bn.

 

In the post-COVID landscape, the company continues to focus on opportunities offering resilient returns and downside protection through structural security and asset backing, with c.94% of the near-term pipeline being structurally secured.

 

The Investment Manager also sees significant opportunities in the real estate sector and SME lending sector, which account for c60% of the near-term pipeline. There is also a focus on ESG within the pipeline, particularly regarding electric vehicle opportunities.

 

We note the recent developments regarding Amigo Holdings Plc and the court's decision to not sanction the scheme of arrangement. We continue to monitor the situation closely with the Honeycomb NAV exposure to Amigo senior secured bonds of £9.8m. As previously disclosed, Honeycomb adopts amortised cost accounting across its credit portfolio including the bond portfolio. This can differ to the on-screen market value of traded securities. As at 26 May 2021, the market value of the Amigo bonds was £8.3m. Amigo combined with other bonds in the Honeycomb portfolio has a NAV exposure of £22.1m, versus a market value as at 26th May of £22.6m.

 

For further information about this announcement please contact:

Pollen Street Capital - Investment Manager

Matthew Potter / Julian Dale: +44 (0)20 3728 6750

Liberum Capital Limited - Joint Broker

Chris Clarke / Louis Davies: +44 (0)20 3100 2000 

Cenkos Securities plc - Joint Broker

Justin Zawoda-Martin: +44 (0)20 7397 8900

Link Company Matters Limited - Corporate Secretary

Paul Johnston: +44 (0)20 7954 9552

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVFLFLREEIRFIL
Date   Source Headline
1st Nov 20213:58 pmRNSDirector Declaration
28th Oct 202110:42 amRNSNAV and Monthly Update August 2021 - Replacement
28th Oct 20217:00 amRNSNAV and Monthly Update September 2021
20th Oct 202111:57 amRNSHolding(s) in Company
1st Oct 20217:05 amRNSDirector Declaration
29th Sep 20217:00 amRNSNAV and Monthly Update September 2021
15th Sep 20217:00 amRNSHalf-year Report
8th Sep 20214:53 pmRNSNotification of Board Committee Changes
8th Sep 20217:00 amRNSDividend Declaration
7th Sep 20217:00 amRNSNAV and Monthly Update - July 2021
28th Jul 20217:00 amRNSNAV and Monthly Update - June 2021
29th Jun 20217:00 amRNSNAV and Monthly Update - May 2021
8th Jun 20215:15 pmRNSResult of AGM
28th May 20219:39 amRNSDirector/PDMR Shareholding
27th May 20217:00 amRNSNAV and Monthly Update - April 2021
14th May 202111:54 amRNSDirector/PDMR Shareholding
10th May 20214:53 pmRNSPosting of Annual Report and Notice of AGM
30th Apr 20217:02 amRNSAnnual Report and Audited Financial Statements
30th Apr 20217:01 amRNSDividend Declaration
30th Apr 20217:00 amRNSNAV and Monthly Update - March 2021
1st Apr 20217:00 amRNSNAV and Monthly Update - February 2021
4th Mar 20217:00 amRNSNAV and Monthly Update - January 2021
26th Feb 20217:00 amRNSDividend Declaration
25th Feb 20214:14 pmRNSBoard Committee Changes & SID Appointment
12th Feb 20217:00 amRNSNAV and Monthly Update - December 2020
12th Jan 20211:43 pmRNSHolding(s) in Company
12th Jan 20211:40 pmRNSHolding(s) in Company
12th Jan 202111:38 amRNSHolding(s) in Company
7th Jan 20217:00 amRNSNAV and Monthly Update - November 2020
29th Dec 202012:22 pmRNSDirectorate Change
18th Dec 202010:21 amRNSKepler Trust Intelligence: New Research
1st Dec 20207:01 amRNSMonthly Update – October 2020
1st Dec 20207:00 amRNSNet Asset Value(s)
20th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
19th Nov 20207:00 amRNSDividend Declaration
19th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
18th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
16th Nov 20204:54 pmRNSHolding(s) in Company
13th Nov 202011:11 amRNSDirector/PDMR Shareholding
13th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
12th Nov 20209:50 amRNSHolding(s) in Company
12th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
11th Nov 20207:00 amRNSShare Buy-Back Programme
6th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
5th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
4th Nov 20207:01 amRNSMonthly Update - September 2020
4th Nov 20207:00 amRNSNet Asset Value(s)
4th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
3rd Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
2nd Nov 20205:01 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.